Kerry M Leehan1,2, Nathan P Pezant1, Astrid Rasmussen1, Kiely Grundahl1, Jacen S Moore1, Lida Radfar3, David M Lewis3, Donald U Stone4, Christopher J Lessard1,2, Nelson L Rhodus5, Barbara M Segal6, C Erick Kaufman7, R Hal Scofield1,7,8, Kathy L Sivils1,2, Courtney Montgomery1, A Darise Farris1,2. 1. a Arthritis and Clinical Immunology Program , Oklahoma Medical Research Foundation (OMRF) , Oklahoma City , OK , USA. 2. b Department of Pathology , University of Oklahoma Health Sciences Center (OUHSC) , Oklahoma City , OK , USA. 3. c College of Dentistry , OUHSC , Oklahoma City , OK , USA. 4. d Department of Ophthalmology , Johns Hopkins University , Baltimore , MD , USA. 5. e Division of Oral Medicine and Diagnosis, Department of Diagnostic and Biological Sciences, School of Dentistry , University of Minnesota , Minneapolis , MN , USA. 6. f Division of Rheumatic and Autoimmune Diseases , University of Minnesota , Minneapolis , MN , USA. 7. g Department of Medicine , OUHSC , Oklahoma City , OK , USA. 8. h Department of Veteran's Affairs Medical Center , Oklahoma City , OK , USA.
Abstract
OBJECTIVE: Determine the presence and assess the extent of fatty infiltration of the minor salivary glands (SG) of primary SS patients (pSS) as compared to those with non-SS sicca (nSS). METHODS: Minor SG biopsy samples from 134 subjects with pSS (n = 72) or nSS (n = 62) were imaged. Total area and fatty replacement area for each glandular cross-section (n = 4-6 cross-sections per subject) were measured using Image J (National Institutes of Health, Bethesda, MD). The observer was blinded to subject classification status. The average area of fatty infiltration calculated per subject was evaluated by logistic regression and general linearized models (GLM) to assess relationships between fatty infiltration and clinical exam results, extent of fibrosis and age. RESULTS: The average area of fatty infiltration for subjects with pSS (median% (range) 4.97 (0.05-30.2)) was not significantly different from that of those with nSS (3.75 (0.087-41.9). Infiltration severity varied widely, and subjects with fatty replacement greater than 6% were equivalently distributed between pSS and nSS participants (χ2 p = .50). Age accounted for all apparent relationships between fatty infiltration and fibrosis or reduced saliva flow. The all-inclusive GLM for prediction of pSS versus non-SS classification including fibrosis, age, fatty replacement, and focus score was not significantly different from any desaturated model. In no iteration of the model did fatty replacement exert a significant effect on the capacity to predict pSS classification. CONCLUSIONS: Fatty infiltration is an age-associated phenomenon and not a selective feature of Sjögren's syndrome. Sicca patients who do not fulfil pSS criteria have similar rates of fatty infiltration of the minor SG.
OBJECTIVE: Determine the presence and assess the extent of fatty infiltration of the minor salivary glands (SG) of primary SS patients (pSS) as compared to those with non-SS sicca (nSS). METHODS: Minor SG biopsy samples from 134 subjects with pSS (n = 72) or nSS (n = 62) were imaged. Total area and fatty replacement area for each glandular cross-section (n = 4-6 cross-sections per subject) were measured using Image J (National Institutes of Health, Bethesda, MD). The observer was blinded to subject classification status. The average area of fatty infiltration calculated per subject was evaluated by logistic regression and general linearized models (GLM) to assess relationships between fatty infiltration and clinical exam results, extent of fibrosis and age. RESULTS: The average area of fatty infiltration for subjects with pSS (median% (range) 4.97 (0.05-30.2)) was not significantly different from that of those with nSS (3.75 (0.087-41.9). Infiltration severity varied widely, and subjects with fatty replacement greater than 6% were equivalently distributed between pSS and nSSparticipants (χ2 p = .50). Age accounted for all apparent relationships between fatty infiltration and fibrosis or reduced saliva flow. The all-inclusive GLM for prediction of pSS versus non-SS classification including fibrosis, age, fatty replacement, and focus score was not significantly different from any desaturated model. In no iteration of the model did fatty replacement exert a significant effect on the capacity to predict pSS classification. CONCLUSIONS: Fatty infiltration is an age-associated phenomenon and not a selective feature of Sjögren's syndrome. Siccapatients who do not fulfil pSS criteria have similar rates of fatty infiltration of the minor SG.
Entities:
Keywords:
Sjögren’s syndrome; aging; fatty replacement; minor salivary gland; pathology
Authors: Michelle L Joachims; Kerry M Leehan; Christina Lawrence; Richard C Pelikan; Jacen S Moore; Zijian Pan; Astrid Rasmussen; Lida Radfar; David M Lewis; Kiely M Grundahl; Jennifer A Kelly; Graham B Wiley; Mikhail Shugay; Dmitriy M Chudakov; Christopher J Lessard; Donald U Stone; R Hal Scofield; Courtney G Montgomery; Kathy L Sivils; Linda F Thompson; A Darise Farris Journal: JCI Insight Date: 2016-06-02
Authors: F Carubbi; A Alunno; P Cipriani; E Bartoloni; C Baldini; L Quartuccio; R Priori; G Valesini; S De Vita; S Bombardieri; R Gerli; R Giacomelli Journal: Lupus Date: 2014-10-08 Impact factor: 2.911
Authors: Mario García-Carrasco; Salvador Fuentes-Alexandro; Ricardo O Escárcega; Gonzalo Salgado; Carlos Riebeling; Ricard Cervera Journal: Arch Med Res Date: 2006-11 Impact factor: 2.235
Authors: C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita Journal: Arthritis Rheum Date: 1993-03
Authors: Anna P Risselada; Aike A Kruize; Roel Goldschmeding; Floris P J G Lafeber; Johannes W J Bijlsma; Joel A G van Roon Journal: Ann Rheum Dis Date: 2014-02-13 Impact factor: 19.103
Authors: Leyla Y Teos; Yu Zhang; Ana P Cotrim; William Swaim; Jon H Won; Julian Ambrus; Long Shen; Lolita Bebris; Margaret Grisius; Shyh-Ing Jang; David I Yule; Indu S Ambudkar; Ilias Alevizos Journal: Sci Rep Date: 2015-09-14 Impact factor: 4.379
Authors: Brij B Singh; Joyce Ohm; Fredice O Quenum Zanbede; Pooja Chauhan; Frans G M Kroese; Arjan Vissink; Julian L Ambrus; Bibhuti B Mishra Journal: Autoimmunity Date: 2020-05-25 Impact factor: 2.815
Authors: Roland Jonsson; Karl A Brokstad; Malin V Jonsson; Nicolas Delaleu; Kathrine Skarstein Journal: Eur J Oral Sci Date: 2018-10 Impact factor: 2.612
Authors: Akinsola Oyelakin; Erich Horeth; Eun-Ah Christine Song; Sangwon Min; Monika Che; Brandon Marzullo; Christopher J Lessard; Astrid Rasmussen; Lida Radfar; R Hal Scofield; David M Lewis; Donald U Stone; Kiely Grundahl; Scott S De Rossi; Zoya Kurago; A Darise Farris; Kathy L Sivils; Satrajit Sinha; Jill M Kramer; Rose-Anne Romano Journal: Front Immunol Date: 2021-01-08 Impact factor: 7.561
Authors: Esther Mossel; Martha S van Ginkel; Erlin A Haacke; Suzanne Arends; Silvia C Liefers; Konstantina Delli; Jolien F van Nimwegen; Alja J Stel; Fred K L Spijkervet; Arjan Vissink; Bert van der Vegt; Frans G M Kroese; Hendrika Bootsma Journal: Rheumatology (Oxford) Date: 2022-05-30 Impact factor: 7.046
Authors: Tamandeep K Bharaj; Lara A Aqrawi; Siren Fromreide; Roland Jonsson; Johan G Brun; Silke Appel; Kathrine Skarstein Journal: Front Immunol Date: 2021-07-12 Impact factor: 7.561